New hope for kidney patients around the world with investment into Australian dialysis device manufacture
Sydney-based start-up Ellen Medical Devices will receive $427,500 in government funding that will be...
07 October, 2021
New frontiers
George
Clinical
Science, service, solutions. A leading contract research organisation in Asia-Pacific with global capabilities.
Novel Treatments
George
Medicines
Innovative, affordable treatments for the leading causes of death globally.
Disruptive technologies
George Health Technologies
Affordable, personalised digital health care for all.
A leader in global health
The George Institute for Global Health
All the George Health businesses benefit from exclusive access to the research, intellectual property, and scientific expertise of The George Institute for Global Health – a world-leading, global medical research institute focused on the biggest killers: non-communicable diseases and injury.
Non-communicable diseases – a unique 21st century global health challenge
~4 billion
1/2 the world’s population does not have access to the health services they need.
Each year, 100 million people are pushed into poverty because of out-of-pocket health costs.
100 million
100 million people will die from chronic diseases before they reach 60.
Heart attack and stroke are the world’s leading cause of death.
US$47 trillion
The United Nations has projected cumulative losses to the global economy due to chronic disease could reach US$47 trillion by 2030.
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on provid...
12 July, 2021
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood pr...
01 July, 2021
The George Institute Annual Report 2020
For George Health, 2019 and 2020 were watershed years. Multiple investors stepped forward to complete a capital raise of $53 million to back George Health’s ‘profit with purpose’ vision: improving and lengthening people’s lives, boosting health system sustainability and generating strong financial returns.
Read our year in review in The George Institute’s Annual Report 2020.